1-(4-nitrofenil)-4(5)-(4-xlorfenoksimetil)-1n-1,2,3-triazol izomerlarining xromatografik tadqiqi va IQ-spektrlar tahlili natijalari

18.08.2021 Научный вестник. Серия: Общественные науки №7 5-15
Автор:

Jasurbek Shuxratbekovich MAMAJONOV

O'zbekiston Milliy universiteti umumiy va neft-gaz kimyo kafedrasi tayanch doktoranti. E-mail: ximik.mamajonov@mail.ru

Аннотация:
p-Xlorfenoksipropargil va p-nitrofenilazid asosida 1-, 3-dipolyar siklobirikishreaksiyasi amalga oshirildi. Efir molekulasi nosimmetrik tuzilishga ega bo'lganligi uchun dipolyar siklobirikish reaksiyasi ikkita izomer hosil qilish bilan boradi. Izomerlar yupqa qatlamli xromatografiya usulida tasdiqlanib, Rf qiymatlari aniqlandi va izomerlar kolonkali xromatografiya usulida ajratilib, miqdoriy nisbatlari ko'rsatildi, ularning tuzilishi IQ-spektroskopiya usuli yordamida tasdiqlandi.
Литература:
1. Ahmad S., Alam O., Naim M.J., Shaquiquzzaman M, Alam MM, Iqbal M. Pyrrole: an insight into recent pharmacological advances with structure activity relationship // European Journal of Medicinal Chemistry, 2018. - Vol. 157. - Pp. 527 - 561.
2. Parker W.B. Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer // Chemical Reviews, 2009. - Vol. 109. - Pp. 2880 - 2893.
3. Bozorov K, Nie LF, Zhao J, Aisa H.A. 2-Aminothiophene scaffolds: diverse biological and pharmacological attributes in medicinal chemistry // European Journal of Medicinal Chemistry, 2017. -Vol. 140. - Pp. 465 - 493.
4. Bozorov K, Zhao J-Y, Elmuradov B, Pataer A, Aisa HA. Recent developments regarding the use of thieno [2,3-d]pyrimidin-4-one derivatives in medicinal chemistry, with a focus on their synthesis and anticancer properties // European Journal of Medicinal Chemistry, 2015. - Vol. 102.- Pp. 552 - 573.
5. Bozorov K., Ma H-R., Zhao J-Y., Zhao H-Q., Chen H., Bobakulov Kh., Xin X-L., Elmuradov B.,Shakhidoyatov Kh., Aisa H.A. Discovery of diethyl 2,5- diaminothiophene-3-,4- dicarboxylate derivatives as potent anticancer and antimicrobial agents and screening of anti-diabetic activity:synthesis and in vitro biological evaluation Part 1 // European Journal of Medicinal Chemistry, 2014.- Vol. 84. - Pp. 739 - 745.
6. Bozorov K, Jy Zhao, Nie LF, Ma H-R., Bobakulov Kh., Hu R., Rustamova N., Huang G., Efferthd T.,Aisa H. A. Synthesis and in vitro biological evaluation of novel diaminothiophene scaffolds as antitumor and anti-influenza virus agents. Part 2 // RSC Advances, 2017. - Vol. 7. - Pp. 31417 -31427.
7. Khanam H, Shamsuzzaman. Bioactive Benzofuran derivatives: a review // European Journal of Medicinal Chemistry, 2015. - Vol. 97. - Pp. 483 - 504.
8. Naik R., Harmalkar D.S., Xu X., Jang K., Lee K. Bioactive benzofuran derivatives: moracins A-Z in medicinal chemistry // European Journal of Medicinal Chemistry, 2015. - Vol. 90. - Pp. 379 - 393.
9. Majumdar P., Pati A., Patra M., Behera R.K., Behera A.K. Acid hydrazides, potent reagents for synthesis of oxygen-, nitrogen-, and/or sulfur-containing heterocyclic rings // Chemical Reviews,2014. - Vol. 114. - Pp. 2942 - 2977.
10. Ayati A., Emami S., Foroumadi A. The importance of triazole scaffold in the development of anticonvulsant agents // European Journal of Medicinal Chemistry, 2016. - Vol. 109. - Pp. 380 - 392.
11. Briguglio I., Piras S., Corona P., et al. Benzotriazole: an overview on its versatile biological behavior // European Journal of Medicinal Chemistry, 2015. -Vol. 97. - Pp. 612 - 648.
12. Abdellatif K.R.A., Bakr R.B. New advances in synthesis and clinical aspects of pyrazolo [3,4-d]pyrimidine scaffolds // Bioorganic Chemistry, 2018. - Vol. 78. - Pp. 341 - 357.
13. Kommidi H., Guo H., Nurili F., Ed-yas Y., Jin O., Clure T.D., Ehdaie B., Sayman H.B., Akin O.,Aras O., Ting R. 18F-positron emitting/trimethine-cyaninefluorescent contrast for image-guided prostate cancer management // Journal of Medicinal Chemistry, 2018. - Vol. 61. - Pp. 4256 - 4262.
14. Huang S., Han Y., Chen M., Hu K., Qi Y., Sun P., Wang M., Wu H., Li G., Wang Q., Du Z., Zhang K.,Zhao S., Zheng X. Radiosynthesis and biological evaluation of 18F-labeled 4-anilinoquinazoline derivative (18F-FEA-Erlotinib) as a potential EGFR PET agent // Bioorganic & Medicinal Chemistry Letters, 2018. -Vol. 28. - Pp. 1143 - 1148.
Для цитирования:
Mamajonov J., Abdug'afurov I., Ortiqov I., Madixonov N. 1-(4-nitrofenil)-4(5)-(4-xlorfenoksimetil)-1n-1,2,3-triazol izomerlarining xromatografik tadqiqi va IQ-spektrlar tahlili natijalari. Ilmiy xabarnoma. Seriya: Kimyo tadqiqotlari - Scientific Bulletin. Chemical Research. 2020. 7(51).5 - 15.